MedTrace Logo

MPC Versus PID for Closed Loop Insulin Delivery

NCT02438670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-07-22

No results posted yet for this study

Summary

The goal of this proposed study is to compare use of a PID (Proportional-Integral-Derivative) controller versus an MPC (Model Predictive Control) controller algorithm in an artificial pancreas system, all other components and study design being equal. The study design, power calculation and endpoints were developed based on the results of an initial feasibility study (ClinicalTrials.gov Identifier: NCT01987206) that has already been completed.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

PID control algorithm

DEVICE

MPC control algorithm

Sponsors & Collaborators

  • University of California, Santa Barbara

    collaborator OTHER

  • Sansum Diabetes Research Institute

    lead OTHER

Principal Investigators

  • Jordan E Pinsker, MD · Sansum Diabetes Research Institute

  • Eyal Dassau, PhD · University of California, Santa Barbara

  • Francis J Doyle III, PhD · University of California, Santa Barbara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438670 on ClinicalTrials.gov